China’s demand for high-end healthcare services and products, as well as advanced medical devices to treat chronic diseases and take care of their elder population has increased rapidly over the past few years. 

 

Strong growth in the healthcare sector is fueled by favorable demographic trends, continuing urbanization, an increasing disease burden, the overall economy’s healthy expansion, and income growth (which encourages greater awareness of and access to treatments).

​

In order to tap into this demand, Chinese companies have been stepping up their overseas investment in the healthcare sector in North American companies. Their objective is to access technology, expertise and high-quality brands that can be adapted to satisfy the needs of the Chinese market.